- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有38家主力机构披露2025-12-31报告期持股数据，持仓量总计165.35万股，占流通A股0.71%
- 波段诊断：
-
技术面诊股
诊断结果：6.4技术面打败了61%的股票
技术面评分前10的股票
近期的平均成本为7.66元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为7.66元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"7.66","date":1776743071,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑输行业平均水平。
[{"date":"2026.04.21","stock":"-0.13","trade":"-0.57","ind":"0.10"},{"date":"2026.04.20","stock":"1.99","trade":"0.15","ind":"0.55"},{"date":"2026.04.17","stock":"-5.40","trade":"-1.52","ind":"0.60"},{"date":"2026.04.16","stock":"0.38","trade":"-0.13","ind":"2.05"},{"date":"2026.04.15","stock":"1.93","trade":"2.03","ind":"-0.97"},{"date":"2026.04.14","stock":"-0.38","trade":"0.36","ind":"1.61"},{"date":"2026.04.13","stock":"-1.76","trade":"-1.82","ind":"0.69"},{"date":"2026.04.10","stock":"1.15","trade":"0.01","ind":"2.24"},{"date":"2026.04.09","stock":"-3.32","trade":"-1.54","ind":"-0.33"},{"date":"2026.04.08","stock":"-0.73","trade":"0.62","ind":"4.79"},{"date":"2026.04.07","stock":"3.28","trade":"0.87","ind":"0.36"},{"date":"2026.04.03","stock":"-3.76","trade":"-2.39","ind":"-0.99"},{"date":"2026.04.02","stock":"-0.72","trade":"0.62","ind":"-1.60"},{"date":"2026.04.01","stock":"2.34","trade":"2.36","ind":"1.70"},{"date":"2026.03.31","stock":"-0.86","trade":"-0.69","ind":"-1.81"},{"date":"2026.03.30","stock":"1.49","trade":"1.18","ind":"-0.25"},{"date":"2026.03.27","stock":"3.73","trade":"2.53","ind":"1.13"},{"date":"2026.03.26","stock":"-1.27","trade":"-0.80","ind":"-1.41"},{"date":"2026.03.25","stock":"1.81","trade":"1.38","ind":"1.95"},{"date":"2026.03.24","stock":"6.77","trade":"3.44","ind":"1.43"},{"date":"2026.03.23","stock":"-8.12","trade":"-5.85","ind":"-3.76"}]
益盛药业,深证成指,中药指数
压力支撑
该股压力位为7.65元，支撑位为7.57元。
[{"text":"\u538b\u529b\u4f4d","value":"7.65","date":1776700800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"7.57","date":1776700800,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.5资金面打败了72%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：04月22日 12:48
| 机构今日流向(万元) | -2003.80 | 机构5日流向(万元) | -4673.69 |
| 机构10日流向(万元) | -13594.17 | 机构20日流向(万元) | -10522.14 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量增加108.77万股，其中基金数没有增加，主力净增仓26家，有一定的中长期投资价值。
截止2025-12-31，共38家主力机构（基金38家），持仓量总计165.35万股，占流通A股0.71%
其中，基金持仓与2025-06-30相比：
增仓：2家 ，增持 5.03万股
减仓：2家 ，减持 1.23万股
新出现在主力名单中：34家 ，持有133.23万股
从主力名单中消失：8家 ，原持有28.26万股
其中，基金持仓与2025-06-30相比：
增仓：2家 ，增持 5.03万股
减仓：2家 ，减持 1.23万股
新出现在主力名单中：34家 ，持有133.23万股
从主力名单中消失：8家 ，原持有28.26万股
消息面诊股
诊断结果：6.6消息面打败了70%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 益盛药业2025年营收6.40亿元，归母净利润28
2026-04-17 - 财报速递：益盛药业2025年全年净利润2899.9
2026-04-17 - 益盛药业：2025年净利润2899.93万元，同比
2026-04-16 - 益盛药业（截止2026年4月10日）股东人数为20
2026-04-13 - 益盛药业（截止2026年3月31日）股东人数为20
2026-04-02 - 【行业深度】洞察2025：中国仿制药行业竞争格局及
2026-03-27 - 益盛药业（截止2026年3月20日）股东人数为20
2026-03-24 - 益盛药业（截止2026年3月10日）股东人数为20
2026-03-12 - 【最全】2025年毛发医疗行业上市公司全方位对比（
2026-03-06 - 益盛药业（截止2026年2月27日）股东人数为21
2026-03-04
消息列表
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-17 |
| 利好 | 分红转增 | 10派0.8元(含税) | 2026-04-17 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-12 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-23 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：5.8行业面打败了68%的股票
中药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2026.04.21","price":"0.10","value":"-0.57"},{"date":"2026.04.20","price":"0.55","value":"0.15"},{"date":"2026.04.17","price":"0.60","value":"-1.52"},{"date":"2026.04.16","price":"2.05","value":"-0.13"},{"date":"2026.04.15","price":"-0.97","value":"2.03"},{"date":"2026.04.14","price":"1.61","value":"0.36"},{"date":"2026.04.13","price":"0.69","value":"-1.82"},{"date":"2026.04.10","price":"2.24","value":"0.01"},{"date":"2026.04.09","price":"-0.33","value":"-1.54"},{"date":"2026.04.08","price":"4.79","value":"0.62"},{"date":"2026.04.07","price":"0.36","value":"0.87"},{"date":"2026.04.03","price":"-0.99","value":"-2.39"},{"date":"2026.04.02","price":"-1.60","value":"0.62"},{"date":"2026.04.01","price":"1.70","value":"2.36"},{"date":"2026.03.31","price":"-1.81","value":"-0.69"},{"date":"2026.03.30","price":"-0.25","value":"1.18"},{"date":"2026.03.27","price":"1.13","value":"2.53"},{"date":"2026.03.26","price":"-1.41","value":"-0.80"},{"date":"2026.03.25","price":"1.95","value":"1.38"},{"date":"2026.03.24","price":"1.43","value":"3.44"},{"date":"2026.03.23","price":"-3.76","value":"-5.85"}]
深证成指,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 万邦德 | 54.97% | -2.82% | 5.0分 |
| 2 | 益佰制药 | 39.42% | 11.09% | 3.7分 |
| 3 | 康惠股份 | 38.72% | 19.04% | 5.3分 |
| 4 | 沃华医药 | 30.15% | -0.77% | 5.5分 |
| 5 | ST香雪 | 14.54% | 5.72% | 5.3分 |
| 6 | 康恩贝 | 13.30% | 5.50% | 5.3分 |
| 8 | 太龙药业 | 12.13% | -2.06% | 5.3分 |
| 10 | 九芝堂 | 11.68% | -1.26% | 4.9分 |
| 12 | ST葫芦娃 | 11.11% | -2.72% | 4.9分 |
| 14 | 陇神戎发 | 10.01% | 0.00% | 5.8分 |
| 16 | - | 9.02% | 2.49% | 分 |
| 18 | 精华制药 | 8.41% | -2.39% | 5.4分 |
| 20 | 粤万年青 | 7.77% | -2.11% | 4.6分 |
| 22 | 仁和药业 | 7.68% | -1.37% | 4.8分 |
| 24 | 步长制药 | 7.49% | 1.91% | 5.2分 |
| 26 | 亚宝药业 | 7.05% | -0.15% | 5.3分 |
| 28 | 新天药业 | 6.94% | -2.85% | 4.8分 |
| 30 | 红日药业 | 6.17% | -3.10% | 4.7分 |
| 32 | 维康药业 | 6.06% | 0.90% | 4.8分 |
| 34 | 千金药业 | 5.84% | 0.10% | 6.2分 |
| 36 | 上海凯宝 | 5.69% | 0.34% | 5.0分 |
| 38 | 三力制药 | 5.53% | 0.64% | 5.3分 |
| 40 | 佛慈制药 | 5.29% | -2.11% | 5.2分 |
| 42 | 吉林敖东 | 4.83% | -2.89% | 5.0分 |
| 44 | 天士力 | 4.36% | 1.07% | 5.4分 |
| 46 | 特一药业 | 3.53% | -3.03% | 5.3分 |
| 48 | 葵花药业 | 2.86% | 0.08% | 4.2分 |
| 50 | 珍宝岛 | 2.27% | -1.17% | 4.6分 |
| 52 | 天目药业 | 1.20% | -1.63% | 5.2分 |
| 54 | 方盛制药 | 0.58% | -1.60% | 5.6分 |
| 56 | 达仁堂 | 0.20% | -0.34% | 5.6分 |
| 58 | 马应龙 | -0.32% | -1.43% | 5.1分 |
| 60 | 羚锐制药 | -0.97% | 0.37% | 5.6分 |
| 62 | 古汉医药 | -1.42% | -1.94% | 5.9分 |
| 64 | 同仁堂 | -2.90% | -0.89% | 5.4分 |
| 66 | 济川药业 | -3.53% | -0.88% | 5.0分 |
| 68 | 片仔癀 | -5.23% | -3.00% | 4.3分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-12-31 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 22/107 ， 3/107。
[{"date":"2025-12-31","value":"1.30","vol":"5.93"},{"date":"2025-09-30","value":"1.08","vol":"4.81"},{"date":"2025-06-30","value":"0.84","vol":"4.04"},{"date":"2025-03-31","value":"0.53","vol":"2.25"},{"date":"2024-12-31","value":"2.33","vol":"4.87"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
1.30 | 1.08 | 0.84 | 0.53 | 2.33 |
| 行业(%) | 5.93 | 4.81 | 4.04 | 2.25 | 4.87 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"73.99","vol":"49.38"},{"date":"2025-09-30","value":"75.11","vol":"53.26"},{"date":"2025-06-30","value":"75.15","vol":"53.79"},{"date":"2025-03-31","value":"74.88","vol":"54.43"},{"date":"2024-12-31","value":"74.47","vol":"53.69"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
73.99 | 75.11 | 75.15 | 74.88 | 74.47 |
| 行业(%) | 49.38 | 53.26 | 53.79 | 54.43 | 53.69 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 13/107 ， 26/107。
[{"date":"2025-12-31","value":"-4.23","vol":"-5.77"},{"date":"2025-09-30","value":"-5.81","vol":"-7.81"},{"date":"2025-06-30","value":"-5.75","vol":"-7.74"},{"date":"2025-03-31","value":"-20.59","vol":"-7.31"},{"date":"2024-12-31","value":"-21.69","vol":"-6.13"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-4.23 | -5.81 | -5.75 | -20.59 | -21.69 |
| 行业(%) | -5.77 | -7.81 | -7.74 | -7.31 | -6.13 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"-44.32","vol":"-127.23"},{"date":"2025-09-30","value":"-32.72","vol":"-2.50"},{"date":"2025-06-30","value":"-43.71","vol":"2.58"},{"date":"2025-03-31","value":"-43.56","vol":"-37.35"},{"date":"2024-12-31","value":"-45.02","vol":"-148.45"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-44.32 | -32.72 | -43.71 | -43.56 | -45.02 |
| 行业(%) | -127.23 | -2.50 | 2.58 | -37.35 | -148.45 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 27/107 ， 29/107。
[{"date":"2025-12-31","value":"0.22","vol":"0.50"},{"date":"2025-09-30","value":"0.16","vol":"0.35"},{"date":"2025-06-30","value":"0.11","vol":"0.24"},{"date":"2025-03-31","value":"0.05","vol":"0.13"},{"date":"2024-12-31","value":"0.22","vol":"0.50"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.22 | 0.16 | 0.11 | 0.05 | 0.22 |
| 行业(次) | 0.50 | 0.35 | 0.24 | 0.13 | 0.50 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"0.10","vol":"2.34"},{"date":"2025-09-30","value":"0.07","vol":"1.72"},{"date":"2025-06-30","value":"0.05","vol":"1.17"},{"date":"2025-03-31","value":"0.02","vol":"0.60"},{"date":"2024-12-31","value":"0.11","vol":"2.41"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.10 | 0.07 | 0.05 | 0.02 | 0.11 |
| 行业(次) | 2.34 | 1.72 | 1.17 | 0.60 | 2.41 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 5/107 ， 6/107。
[{"date":"2025-12-31","value":"34.88","vol":"23.35"},{"date":"2025-09-30","value":"5.53","vol":"10.53"},{"date":"2025-06-30","value":"6.70","vol":"22.82"},{"date":"2025-03-31","value":"13.85","vol":"2.07"},{"date":"2024-12-31","value":"10.91","vol":"22.07"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 34.88 | 5.53 | 6.70 | 13.85 | 10.91 |
| 行业 | 23.35 | 10.53 | 22.82 | 2.07 | 22.07 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"0.31","vol":"0.79"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.39","vol":"1.03"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.33","vol":"1.48"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.31 | - | 0.39 | - | 0.33 |
| 行业 | 0.79 | 0.00 | 1.03 | 0.00 | 1.48 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 28/107 ， 23/107。
[{"date":"2025-12-31","value":"6.24","vol":"2.80"},{"date":"2025-09-30","value":"5.82","vol":"3.09"},{"date":"2025-06-30","value":"5.62","vol":"2.94"},{"date":"2025-03-31","value":"5.85","vol":"3.03"},{"date":"2024-12-31","value":"6.49","vol":"2.92"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 流动比率 |
6.24 | 5.82 | 5.62 | 5.85 | 6.49 |
| 行业 | 2.80 | 3.09 | 2.94 | 3.03 | 2.92 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"2.10","vol":"2.06"},{"date":"2025-09-30","value":"1.93","vol":"2.24"},{"date":"2025-06-30","value":"1.85","vol":"2.15"},{"date":"2025-03-31","value":"1.94","vol":"2.24"},{"date":"2024-12-31","value":"2.04","vol":"2.13"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 速动比率 |
2.10 | 1.93 | 1.85 | 1.94 | 2.04 |
| 行业 | 2.06 | 2.24 | 2.15 | 2.24 | 2.13 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 22/107 ， 23/107。
[{"date":"2025-12-31","value":"21.30","vol":"34.28"},{"date":"2025-09-30","value":"22.08","vol":"31.59"},{"date":"2025-06-30","value":"22.61","vol":"32.44"},{"date":"2025-03-31","value":"22.14","vol":"31.90"},{"date":"2024-12-31","value":"21.45","vol":"32.73"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
21.30 | 22.08 | 22.61 | 22.14 | 21.45 |
| 行业(%) | 34.28 | 31.59 | 32.44 | 31.90 | 32.73 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-12-31","value":"0.28","vol":"0.79"},{"date":"2025-09-30","value":"0.30","vol":"0.76"},{"date":"2025-06-30","value":"0.31","vol":"0.75"},{"date":"2025-03-31","value":"0.30","vol":"0.74"},{"date":"2024-12-31","value":"0.28","vol":"0.76"}]
| 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.28 | 0.30 | 0.31 | 0.30 | 0.28 |
| 行业(%) | 0.79 | 0.76 | 0.75 | 0.74 | 0.76 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"0.83","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.95","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"0.52","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.29","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]